HomeATRA • NASDAQ
add
Atara Biotherapeutics Inc
Previous close
$10.61
Day range
$10.38 - $11.48
Year range
$6.50 - $39.50
Market cap
64.96M USD
Avg Volume
126.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 40.19M | 1,779.79% |
Operating expense | 10.42M | -14.91% |
Net income | -21.91M | 68.61% |
Net profit margin | -54.51 | 98.33% |
Earnings per share | -2.93 | 82.24% |
EBITDA | -20.53M | 69.99% |
Effective tax rate | 0.08% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 67.19M | -34.39% |
Total assets | 142.71M | -24.41% |
Total liabilities | 233.24M | -2.66% |
Total equity | -90.54M | — |
Shares outstanding | 5.76M | — |
Price to book | -0.67 | — |
Return on assets | -41.84% | — |
Return on capital | 110.10% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -21.91M | 68.61% |
Cash from operations | -3.99M | 92.23% |
Cash from investing | -16.66M | -123.66% |
Cash from financing | 35.79M | 17,308.17% |
Net change in cash | 15.14M | -19.87% |
Free cash flow | 2.82M | 110.96% |
About
Founded
2012
Headquarters
Website
Employees
159
